Reference | </br>1:Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules. Tan Y, Si X, Zhong L, Feng X, Yang X, Huang M, Wu C.Drug Dev Ind Pharm. 2016 Oct;42(10):1669-77. doi: 10.3109/03639045.2016.1161644. Epub 2016 Apr 11. PMID: 27066697 Free PMC Article</br>2:Development and validation of HPLC-DAD method for the simultaneous determination of amoxicillin, metronidazole and rabeprazole sodium. Application to spiked simulated intestinal fluid samples. Sabry SM, Abdel-Hay MH, Belal TS, Mahgoub AA.Ann Pharm Fr. 2015 Sep;73(5):351-60. doi: 10.1016/j.pharma.2015.04.008. Epub 2015 May 27. PMID: 26024556 </br>3:A study of selective spectrophotometric methods for simultaneous determination of Itopride hydrochloride and Rabeprazole sodium binary mixture: Resolving sever overlapping spectra. Mohamed HM.Spectrochim Acta A Mol Biomol Spectrosc. 2015 Feb 5;136 Pt C:1308-15. doi: 10.1016/j.saa.2014.10.018. Epub 2014 Oct 28. PMID: 25456673 </br>4:Liquid chromatography coupled with fluorimetric detection and third derivative synchronous fluorescence spectroscopy as two analytical methods for the simultaneous determination of rabeprazole sodium and domperidone after derivatization with 4-chloro-7-nitrobenzofurazan. Ibrahim F, Wahba ME.J Fluoresc. 2014 Jul;24(4):1137-47. doi: 10.1007/s10895-014-1394-z. Epub 2014 Jun 3. PMID: 24882601 </br>5:Development and Validation of a Stability-Indicating RP-HPLC Method for the Determination of Process-Related Impurities and Degradation Products of Rabeprazole Sodium in Pharmaceutical Formulation. Kumar N, Sangeetha D.Sci Pharm. 2013 Mar 17;81(3):697-711. doi: 10.3797/scipharm.1301-25. Print 2013 Jul-Sep. PMID: 24106668 Free PMC Article</br>6:Validation and application of a new reversed phase HPLC method for in vitro dissolution studies of rabeprazole sodium in delayed-release tablets. Nawaz MS.J Anal Methods Chem. 2013;2013:976034. doi: 10.1155/2013/976034. Epub 2013 Aug 22. PMID: 24062966 Free PMC Article</br>7:Design and characterization of enteric-coated controlled release mucoadhesive microcapsules of Rabeprazole sodium. Swain S, Behera UA, Beg S, Sruti J, Patro ChN, Dinda SC, Rao ME.Drug Dev Ind Pharm. 2013 Apr;39(4):548-60. doi: 10.3109/03639045.2012.676047. Epub 2012 Apr 18. PMID: 22512732 </br>8:Rabeprazole sodium delayed-release multiparticulates: Effect of enteric coating layers on product performance. Tirpude RN, Puranik PK.J Adv Pharm Technol Res. 2011 Jul;2(3):184-91. doi: 10.4103/2231-4040.85539. PMID: 22171316 Free PMC Article</br>9:Spectrophotometric methods for simultaneous estimation of rabeprazole sodium and aceclofenac from the combined capsule dosage form. Sawant RL, Hadawale SD, Dhikale GK, Bansode CA, Tajane PS.Pharm Methods. 2011 Jul;2(3):193-7. doi: 10.4103/2229-4708.90362. PMID: 23781455 Free PMC Article</br>10:Identification, isolation and characterization of new impurity in rabeprazole sodium. Rao PS, Ray UK, Gupta PB, Rao DV, Islam A, Rajput P, Mukkanti K.J Pharm Biomed Anal. 2010 Aug 1;52(4):620-4. doi: 10.1016/j.jpba.2010.01.034. Epub 2010 Jan 25. PMID: 20153594
|